$98.52 +0.18 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Jul. 1, 2015 | 04:00 PM

Partner Headlines

  1. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  2. Roche 'High Efficacy' MS Drug Succeeds In Trials

    IBD | Jun. 30, 2015 | 10:42AM EST
  3. Must Watch Stocks for June 29, 2015

    Benzinga | Jun. 29, 2015 | 05:53AM EST
  4. Bill Frels' Stocks With Growing Yields

    GuruFocus | Jun. 27, 2015 | 19:39PM EST
  5. Bill Frels' Stocks With Highest-Growing Yields

    GuruFocus | Jun. 26, 2015 | 17:28PM EST
  6. Just How Big Can Leaders Skyworks, Valeant Grow In Market Cap?

    IBD | Jun. 22, 2015 | 18:52PM EST
  7. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story

    GuruFocus | Jun. 22, 2015 | 18:34PM EST
  8. Mallinckrodt Rebuilding Pattern After Sell Signal

    IBD | Jun. 19, 2015 | 17:45PM EST
  9. Follow Bill Ackman in Valeant Pharmaceuticals

    GuruFocus | Jun. 19, 2015 | 12:32PM EST
  10. Billionaire George Soros Ups Two Stakes in First Quarter

    GuruFocus | Jun. 16, 2015 | 13:01PM EST
  11. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus | Jun. 11, 2015 | 13:41PM EST
  12. Will GlaxoSmithKline Cut Its 6% Dividend?

    GuruFocus | Jun. 3, 2015 | 15:32PM EST
  13. Glaxo sold the OTC products

    IBD | Jun. 2, 2015 | 18:37PM EST
  14. Will Perrigo's Glaxo Buy Make It Too Pricey?

    IBD | Jun. 2, 2015 | 13:08PM EST
  15. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD | May. 26, 2015 | 12:39PM EST
  16. Novartis Reports Two Positive US Phase III Programs in COPD for QVA149, NVA237

    Benzinga | May. 20, 2015 | 11:32AM EST
  17. Glaxo more bullish than Q1

    IBD | May. 6, 2015 | 18:59PM EST
  18. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  19. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  20. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  21. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  22. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  23. Amgen Reports An Upbeat Q1 Earnings

    GuruFocus | Apr. 23, 2015 | 11:36AM EST
  24. Novartis Posts Higher Q1 Profit

    Benzinga | Apr. 23, 2015 | 05:22AM EST
  25. Amgen's Q1 Earnings Paints An Overall Positive Image To Investors

    GuruFocus | Apr. 22, 2015 | 15:46PM EST
  26. Teva Offers $40 Bil For Mylan; Perrigo Rejects Mylan

    IBD | Apr. 21, 2015 | 19:04PM EST
  27. Juno Therapeutics Gets Lift From Cancer Test Results

    IBD | Apr. 21, 2015 | 14:57PM EST
  28. Teva Bids $40 Billion For Mylan, But May Need More

    IBD | Apr. 21, 2015 | 11:35AM EST
  29. In Europe Really Recovering?

    GuruFocus | Apr. 19, 2015 | 18:57PM EST
  30. Amgen's First Drug For Cardiovascular Disease Gets The Green Light

    GuruFocus | Apr. 17, 2015 | 22:41PM EST
  31. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  32. Mylan Scores Final Win In Patent Challenge On Inhalation Drug

    Benzinga | Apr. 17, 2015 | 14:27PM EST
  33. Momenta, Novartis get FDA OK

    IBD | Apr. 16, 2015 | 18:43PM EST
  34. Momenta, Novartis Win FDA Nod For Generic Copaxone

    IBD | Apr. 16, 2015 | 14:39PM EST
  35. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD | Apr. 16, 2015 | 10:50AM EST
  36. Biotech IPOs Ignite As Aduro Doubles On First Day

    IBD | Apr. 15, 2015 | 13:57PM EST
  37. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  38. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  39. Benzinga's M&A Chatter for Wednesday February 25, 2015

    Benzinga | Feb. 25, 2015 | 21:26PM EST
  40. Pharmacyclics hits new high

    IBD | Feb. 25, 2015 | 18:51PM EST
  41. Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside'

    Benzinga | Feb. 25, 2015 | 17:05PM EST
  42. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  43. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD | Feb. 24, 2015 | 10:04AM EST
  44. Hot Income Stocks: Who's Growing Dividends The Fastest?

    IBD | Feb. 23, 2015 | 16:49PM EST
  45. Can These Three BioTech Companies Make It Big?

    GuruFocus | Feb. 20, 2015 | 15:22PM EST
  46. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD | Feb. 17, 2015 | 13:26PM EST
  47. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga | Feb. 13, 2015 | 15:32PM EST
  48. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  49. Credit Suisse Adds 10 Names To European 'Top Picks'

    Benzinga | Feb. 5, 2015 | 07:48AM EST
  50. Stocks That Battle Cancer Were The Best-Performing Biotechs In January

    Benzinga | Jan. 30, 2015 | 13:03PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!